SCHEMBL6435990

SCHEMBL6435990

Cc1cccc(Nc2nc3nonc3nc2NN=Cc2ccc(-c3ccc(Cl)c(C(=O)O)c3)o2)c1C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.78
KDM4E B2RXH2 10/20 0.53
ALDH1A1 P00352 9/20 0.53
MAPT P10636 9/20 0.53
KMT2A Q03164 8/20 0.53
MEN1 O00255 7/20 0.53
GAA P10253 5/20 0.53
HPGD P15428 1/20 0.53
ALOX12 P18054 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
POLB P06746 7/20 0.51
TDP1 Q9NUW8 6/20 0.48
BLM P54132 1/20 0.48
L3MBTL1 Q9Y468 5/20 0.47
PKM P14618 3/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
RECQL P46063 2/20 0.47
CTDSP1 Q9GZU7 2/20 0.47
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8265009 1.00 BIRC5 (0.78) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6435981 1.00 BIRC5 (0.78) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6416280 0.88 BIRC5 (0.59) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6416287 0.88 BIRC5 (0.59) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6414842 0.87 BIRC5 (1.00) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6414850 0.87 BIRC5 (1.00) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL29650064 0.87 BIRC5 (1.00) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6436845 0.86 KDM4E (0.61) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6436849 0.86 KDM4E (0.61) BIRC5KDM4EALDH1A1MAPTKMT2A
SCHEMBL6507461 0.85 BIRC5 (0.67) BIRC5KDM4EALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds 4SC AG (DE) 2005-06-30 US disclosed
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds NR5A2, NR1H2, NR2C2 BIRC5 2525/4885KDM4E 3277/4885ALDH1A1 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.